PROGRAMMABLE CELL THERAPY
Dead / Abandoned — Abandoned — failure to respond (as of 25 May 2022)
What this means for you
This application is over — abandoned 12 May 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97002928
- Mark type
- Stylized text
- Filed
- 30 Aug 2021
- Abandoned
- 12 May 2022
- Attorney of record
- R. Gwen Peterson
Goods and services
- Class 005 — Pharmaceuticals: Biologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions; biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions
Owner
- Arsenal Biosciences, Inc., South San Francisco, CA, US
Prosecution history
- 25 May 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 25 May 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 11 Nov 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Nov 2021 — NON-FINAL ACTION E-MAILED
- 11 Nov 2021 — NON-FINAL ACTION WRITTEN
- 03 Nov 2021 — ASSIGNED TO EXAMINER
- 14 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Sept 2021 — NEW APPLICATION ENTERED